Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-11-05

Clinical Trial Update: Effects of DHEA in Pulmonary Hypertension [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the effects of dehydroepiandrosterone (DHEA) in patients with pulmonary arterial hypertension has completed and results have been pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DHEA (dehydroepiandrosterone)

Snippet

Sponsor: Rhode Island Hospital | Conditions: Pulmonary Arterial Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2025-11-05